BPI

A50

Serving
1 Capsule(s)
Per container
60
Form
capsule-unknown
UPC
851780002285
DSLD
Avoid-flaggedObjective label signals
Flagged excipients
1
1 avoid · 0 caution
FDA recalls
0
no recall history
CAERS reports
2
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

2 active ingredients
IngredientAmount% DV
A50 Proprietary Active Matrix
Proprietary Blend (Metabolite, constituent, extract, isolate, or combination of these)
450 mg
Proprietary Co-Active Matrix
Proprietary Blend (Combination)
0 NP
Flagged excipients

1 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

FDA CAERS · adverse event context
2
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Microcystalline Cellulose · Magnesium Stearate · Gelatin · FD&C Blue No. 1 · Red No. 40 · Yellow No. 6